Dr. Mark Shen performed the surgery using a new system called “Affera Mapping and Ablation” to treat atrial fibrillation.
The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.
MedPage Today on MSN
Metformin Reduced Recurrent Atrial Arrhythmia After Afib Ablation
Over the 3 to 12 months following catheter ablation, patients who received metformin had greater freedom from recurrent ...
Successful catheter ablation resulted in a low risk of stroke associated with atrial fibrillation (AFib), a type of irregular ...
An open-label study shows that patients who took metformin after catheter ablation for atrial fibrillation have significantly ...
Adults with atrial fibrillation with overweight or obesity were less likely to experience recurrent atrial arrhythmia when ...
GlobalData on MSN
Medtronic raises FY26 outlook amid cardiac ablation surge
Medtronic achieved global revenue of almost $9bn in Q2 FY26, with its cardiovascular portfolio contributing $3.44bn.
Medpage Today on MSN
Major Trial Sours on Blanket DOAC Therapy After Successful Afib Ablation
OCEAN was an open-label trial conducted in Australia, Belgium, Canada, China, Germany, and Israel. Eligible participants had ...
The future of heart health is on showcase here in the Quad Cities. Two medical ‘firsts’ were announced last week. A new tool ...
Medtronic posted a slate of strong quarterly financial results this morning, with its cardiovascular device portfolio pushing ...
Hamilton Medical Center pioneers use of Medtronic Sphere-9 ablation tech, boosting precision, safety, and recovery for heart ...
The procedure used to treat arrhythmias typically allows for a short recovery time, but precautions are necessary to preserve healthy heart function. Heart ablation creates little scars on heart ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results